XRCC1 and ovarian cancer: Since we had previously shown that POLβ or XRCC1 deficiency is a predictor of platinum sensitivity in ovarian cancers [35], we investigated whether a synthetic lethality relationship exists between FEN1 and either POLβ or XRCC1.